Considerations for Pharmacologic Management of Rheumatoid Arthritis in the COVID-19 Era: a Narrative Review
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Considerations for Pharmacologic Management of Rheumatoid Arthritis in the COVID-19 Era: a Narrative Review
Authors
Keywords
-
Journal
Current Rheumatology Reports
Volume 25, Issue 11, Pages 236-245
Publisher
Springer Science and Business Media LLC
Online
2023-08-19
DOI
10.1007/s11926-023-01111-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic
- (2023) Alessandra Zaccardelli et al. CURRENT OPINION IN RHEUMATOLOGY
- Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
- (2022) Peter B. Gilbert et al. SCIENCE
- Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial
- (2022) Carlo Scognamiglio Renner Araujo et al. ANNALS OF THE RHEUMATIC DISEASES
- Long COVID after breakthrough SARS-CoV-2 infection
- (2022) Ziyad Al-Aly et al. NATURE MEDICINE
- Sulfasalazine: a risk factor for severe COVID-19?
- (2022) Maximilian F Konig et al. Lancet Rheumatology
- Janus kinase (JAK) inhibitors significantly reduce the humoral vaccination response against SARS-CoV-2 in patients with rheumatoid arthritis
- (2022) Arne Schäfer et al. CLINICAL RHEUMATOLOGY
- Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
- (2022) Obbina Abani et al. LANCET
- Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: A systematic review and meta-analysis
- (2022) Alejandro Piscoya et al. PLoS One
- DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study
- (2022) Michael Di Iorio et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- The impact of temporary methotrexate discontinuation for 1 week versus 2 weeks on seasonal influenza vaccination in patients with rheumatoid arthritis
- (2022) Jin Kyun Park et al. Arthritis & Rheumatology
- Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial
- (2022) Abhishek Abhishek et al. Lancet Respiratory Medicine
- Serological response to SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease treated with disease modifying anti-rheumatic drugs: A cohort study and a meta-analysis
- (2022) Maxime Auroux et al. JOINT BONE SPINE
- Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity
- (2022) Cassandra Calabrese et al. RMD Open
- Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel, assessor-masked, randomised controlled trials
- (2022) Teny Grace Skaria et al. Lancet Rheumatology
- Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study
- (2022) Gabriel Figueroa-Parra et al. Lancet Rheumatology
- Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases
- (2022) Naomi J Patel et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C)
- (2022) Namrata Singh et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease
- (2021) Kristin M D’Silva et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
- (2021) Hannah Bower et al. ANNALS OF THE RHEUMATIC DISEASES
- Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2021) Anja Strangfeld et al. ANNALS OF THE RHEUMATIC DISEASES
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Risk of COVID‐19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At‐Risk Individuals
- (2021) Bryant R. England et al. Arthritis & Rheumatology
- Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2
- (2021) Parakkal Deepak et al. ANNALS OF INTERNAL MEDICINE
- Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
- (2021) Jeffrey A Sparks et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
- (2021) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2
- (2021) Yolanda Braun-Moscovici et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease
- (2021) Rebecca H Haberman et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273
- (2021) Deborah Steensels et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2
- (2021) Jeffrey R. Curtis et al. Arthritis & Rheumatology
- COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
- (2021) Jérôme Avouac et al. Lancet Rheumatology
- Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients With Autoimmune Conditions Treated With Systemic Therapies: A Population-based Study
- (2021) Jeffrey R. Curtis et al. JOURNAL OF RHEUMATOLOGY
- Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
- (2021) Shuo Feng et al. NATURE MEDICINE
- Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US
- (2021) Jing Sun et al. JAMA Internal Medicine
- SARS‐CoV ‐2 Infection and COVID ‐19 Outcomes in Rheumatic Disease: A Systematic Literature Review And Meta‐Analysis
- (2021) Richard Conway et al. Arthritis & Rheumatology
- Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19
- (2021) Zara Izadi et al. JAMA Network Open
- Do JAK inhibitors affect immune response to COVID-19 vaccination? Data from the MAJIK-SFR Registry
- (2021) Raphaèle Seror et al. Lancet Rheumatology
- Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study
- (2021) Ingrid Jyssum et al. Lancet Rheumatology
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2020) Milena Gianfrancesco et al. ANNALS OF THE RHEUMATIC DISEASES
- The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance
- (2020) Zachary S Wallace et al. RHEUMATOLOGY
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
- (2020) Naoki Kaneko et al. CELL
- Concerns, Healthcare Use, and Treatment Interruptions in Patients With Common Autoimmune Rheumatic Diseases During the COVID-19 Pandemic
- (2020) Michael D. George et al. JOURNAL OF RHEUMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now